Ole Andreas Halvorsen
Viking Global Investors
Ole Andreas Halvorsen DaVita HealthCare Partners Inc stake
total: 670
Viking Global Investors DVA trades
- Total transactions:
- 18
- New positions:
- 4
- Sold out:
- 4
- Added:
- 8
- Reduced:
- 2
- Held since:
- 2018 Q4
- Held for:
- 3 quarters
- Latest activity:
- 2019 Q3
According to 2026 Q2 report, Ole Andreas Halvorsen doesn't hold any DaVita HealthCare Partners Inc (DVA) shares. To date, the estimated cost basis is nearly $51.85 for "buy" trades and estimated average "sell" price is $56.26. Viking Global Investors first purchased DVA in 2013 Q4, initially acquiring about 1.57M shares. Ole Andreas Halvorsen later completely sold out the position and invested in DaVita HealthCare Partners Inc again in 2018 Q4. Since the initial investment in DaVita HealthCare Partners Inc (DVA), Viking Global Investors has made 17 more transactions.
When did Ole Andreas Halvorsen sell DaVita HealthCare Partners Inc (DVA)?
Ole Andreas Halvorsen sold off the entire DaVita HealthCare Partners Inc (DVA) position in 2019 Q3.
When did Ole Andreas Halvorsen buy DaVita HealthCare Partners Inc (DVA)?
Ole Andreas Halvorsen first invested in DaVita HealthCare Partners Inc (DVA) in 2013 Q4 at the reported quarter-end price of $63.37 per share.
What's the cost basis of Viking Global Investors's DVA stake?
The estimated cost basis for DaVita HealthCare Partners Inc (DVA) stake is around $51.85 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $51.85
- Weighted AVG sell price:
- $56.26
Ole Andreas Halvorsen's historical trades in DaVita HealthCare Partners Inc
18 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2019 Q3
|
0.00%
|
$56.26
|
-100% (-2,907,034)
|
|||
|
2019 Q2
|
0.73%
|
$56.26
|
+5.50% (+151,529)
|
|||
|
2019 Q1
|
0.86%
|
$54.29
|
+5.55% (+144,876)
|
|||
|
2018 Q4
|
0.76%
|
$51.46
|
new
|
|||
|
2017 Q2
|
0.00%
|
$67.97
|
-100% (-381,597)
|
|||
|
2017 Q1
|
0.11%
|
$67.97
|
new
|
|||
|
2016 Q3
|
0.00%
|
$77.32
|
-100% (-4,611,729)
|
|||
|
2016 Q2
|
1.51%
|
$77.32
|
+164.36% (+2,867,210)
|
|||
|
2016 Q1
|
0.56%
|
$73.38
|
new
|
|||
|
2015 Q4
|
0.00%
|
$72.33
|
-100% (-2,735,075)
|
|||
|
2015 Q3
|
0.76%
|
$72.33
|
-44.95% (-2,233,476)
|
|||
|
2015 Q2
|
1.49%
|
$79.47
|
-21.91% (-1,394,276)
|
|||
|
2015 Q1
|
2.00%
|
$81.28
|
+42.45% (+1,896,087)
|
|||
|
2014 Q4
|
1.55%
|
$75.74
|
+12.20% (+485,570)
|
|||
|
2014 Q3
|
1.17%
|
$73.14
|
+14.10% (+492,086)
|
|||
|
2014 Q2
|
1.10%
|
$72.32
|
+82.00% (+1,571,980)
|
|||
|
2014 Q1
|
0.55%
|
$68.85
|
+22.06% (+346,437)
|
|||
|
2013 Q4
|
0.46%
|
$63.37
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.